<DOC>
	<DOCNO>NCT01488578</DOCNO>
	<brief_summary>The objective surveillance collect information 1 ) adverse drug reaction expect Package Insert ( unknown adverse drug reaction ) , 2 ) incidence adverse drug reaction surveillance , 3 ) factor consider affect safety and/or efficacy drug .</brief_summary>
	<brief_title>Tolterodine Drug Use Investigation . ( Post Marketing Commitment Plan )</brief_title>
	<detailed_description>All subject investigator prescribes first Detrusitol Capsule register consecutively number subject reach target number order extract patient enrol investigation random .</detailed_description>
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Tolterodine Tartrate</mesh_term>
	<criteria>Male female subject intend treat overactive bladder prescribe Detrusitol Capsule physician . Subjects prescribe Detrusitol Capsule .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Overactive Bladder</keyword>
	<keyword>Japanese</keyword>
	<keyword>Tolterodine</keyword>
	<keyword>Detrusitol</keyword>
	<keyword>Detrol</keyword>
	<keyword>Postmarketing commitment plan .</keyword>
</DOC>